NVAX’s Stock Rollercoaster: -25.73% loss in 6 Months, fallen -10.69% in 5 Days

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The metric has seen a significant loss of -45.53% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -25.73%. Over the past 30 days, the price of NVAX has leaped by -12.91%. And in the last five days, it has fallen by -10.69%.

The current stock price for Novavax, Inc. (NVAX) is $5.60. The stock experienced a significant increase during the last trading session, reaching $5.96 after opening at $5.82. It dipped to a low of $5.65 before ultimately closing at $5.73.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


The stock market performance of Novavax, Inc. has been fairly unsteady. Over the last year, the company’s stock hit its highest at $21.34 on 11/21/22, while the lowest price during the same time frame was $5.61, recorded on 11/20/23.

52-week price history of NVAX Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Novavax, Inc.’s current trading price is -73.76% away from its 52-week high, while its distance from the 52-week low is -0.09%. The stock’s price range over this timeframe has been between $5.61 and $21.34. The shares of the Healthcare sector company recorded a trading volume of approximately 2.12 million for the day, which was comparatively lower than the average daily volume of 9.5 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Novavax, Inc. (NVAX) has experienced a quarterly decline of -38.86% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 665.22M and boasts a workforce of 1992 employees.

Expert Opinions: Analysts’ Ratings for Novavax, Inc.

As of right now, 2 analysts are rating Novavax, Inc. as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 7.52, with a change in price of -1.99. Similarly, Novavax, Inc. recorded 8,506,609 in trading volume during the last 100 days, posting a change of -26.20%.

NVAX Stock Stochastic Average

The raw stochastic average for Novavax, Inc. over the last 50 days is presently at 1.38%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 1.99%. Further, the company’s Stochastic %K and %D values for the last 20 days were 3.46% and 8.24%, respectively.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts